Hyperemesis Symptoms: What Could Be Causing Them and What to Do Next

What Hyperemesis Actually Means and Why It Is Not Just Bad Morning Sickness

Hyperemesis gravidarum means uncontrollable vomiting in pregnancy. The word itself comes from Greek and Latin roots meaning excessive vomiting during pregnancy. What separates it from the nausea most pregnant women experience in the first trimester is the degree of severity and its physical consequences.

Typical morning sickness affects up to 80% of pregnant women and, while miserable, does not usually cause weight loss or prevent you from eating and drinking enough to function. Hyperemesis gravidarum, by contrast, is defined by weight loss of at least 5% of pre-pregnancy body weight, dehydration, and electrolyte imbalances, all driven by vomiting that cannot be controlled with rest or ordinary dietary changes.

The condition affects an estimated 0.3 to 3% of pregnancies, but those numbers likely undercount cases because many women are discharged, treated at home, or simply told to eat crackers and push through. The human cost is real: hospitalization, time off work, psychological distress, and in severe or untreated cases, maternal and fetal complications.

What the Symptoms Actually Feel Like

The symptoms of hyperemesis go well beyond queasy mornings. Women describe:

• Nausea that is constant, not confined to mornings
• Vomiting 5 to 10 or more times per day
• Inability to keep down fluids, including water
• Extreme fatigue and weakness
• Dizziness or fainting on standing (orthostatic hypotension from dehydration)
• Unintentional weight loss
• Decreased urine output or dark, concentrated urine
• A persistent metallic or altered taste
• Heightened sensitivity to smells, even mild ones, that instantly trigger vomiting
• Muscle cramps from electrolyte losses (particularly potassium and sodium)

Some women also report ptyalism, excessive salivation that they cannot swallow without vomiting, making the condition even more distressing.

How Symptoms Differ From Ordinary Pregnancy Nausea

| Feature | Typical Morning Sickness | Hyperemesis Gravidarum | |---|---|---| | Timing | Weeks 5 to 14, usually resolves | Weeks 4 to 10 onset; may persist | | Vomiting frequency | Occasional to several times daily | 5 to 10+ times daily | | Weight change | Stable or minimal loss | 5% or more of body weight lost | | Hydration | Maintained | Clinically dehydrated | | Function | Impaired but manageable | Unable to work, care for self | | Hospitalization | Rarely needed | Often required |

What Causes Hyperemesis Symptoms: The Physiology Behind the Misery

No single gene or hormone explains hyperemesis gravidarum, but the leading evidence points to several overlapping biological mechanisms.

The Role of hCG

Human chorionic gonadotropin, the hormone that makes a pregnancy test positive, rises sharply in the first trimester. Higher hCG levels correlate with more severe nausea and vomiting, which explains why conditions that produce more placental tissue, such as molar pregnancies and multiple gestations, carry a higher rate of hyperemesis. The nausea usually peaks when hCG peaks, around weeks 8 to 10, and eases as hCG levels fall after week 12, which is why most women improve in the second trimester.

GDF15 and Sensory Sensitivity

A major 2024 study published in Nature found that growth differentiation factor 15 (GDF15), a hormone produced by the placenta and fetus, is the primary driver of pregnancy nausea and vomiting. Women who had low GDF15 exposure before pregnancy, because of their own genetics or the fetal genotype, appear more sensitive to the surge the placenta produces, leading to more severe symptoms. This research reframes hyperemesis not as a psychological problem or a sign of ambivalence about pregnancy, but as a measurable physiological mismatch.

Estrogen and the Hormonal Environment

Rising estrogen in early pregnancy may contribute to gastric slowing and heightened nausea. Women with higher estrogen levels, including those carrying female fetuses, may be at slightly elevated risk, though the data here is still being clarified. Estrogen also lowers the threshold for vomiting via central mechanisms in the brainstem.

Genetic and Familial Risk Factors

You are 17 times more likely to develop hyperemesis if your mother had it. Sisters of affected women have a similarly elevated risk. Genome-wide association studies have identified variants near the GDF15 and IGFBP7 genes as associated with severe nausea and vomiting of pregnancy. This is a family history worth knowing before you conceive.

Helicobacter Pylori

H. Pylori infection has been detected more frequently in women with hyperemesis than in those with normal pregnancies in several case-control studies. The mechanism is not fully understood, but active H. Pylori infection may amplify gastric sensitivity. Testing for H. Pylori is reasonable if hyperemesis is severe or refractory.

Other Conditions That Cause Similar Symptoms: The Differential Diagnosis

Not every woman with severe vomiting and nausea in pregnancy has hyperemesis gravidarum. Several other conditions can look identical or overlap with it. Missing them can be dangerous.

Thyroid Disorders: Gestational Transient Thyrotoxicosis

HCG cross-reacts with the TSH receptor, and in women with very high hCG levels, this can suppress TSH and raise free T4, a condition called gestational transient thyrotoxicosis (GTT). GTT is found in 60 to 73% of women with hyperemesis and generally resolves as hCG declines without requiring antithyroid medication. However, true Graves' disease can also first present in pregnancy with similar vomiting, palpitations, and weight loss. A TSH and free T4 test distinguishes GTT from Graves' disease, and getting that test matters because Graves' disease requires different management. This is one reason thyroid function testing is recommended in women presenting with hyperemesis.

Gastrointestinal Causes

Several GI conditions can cause severe nausea and vomiting that mimics hyperemesis:

• Gastroenteritis: Usually acute, accompanied by diarrhea, and resolves within a few days
• Peptic ulcer disease: H. Pylori-related; may present with epigastric pain and vomiting
• Gastroesophageal reflux disease (GERD): Very common in pregnancy; often coexists with HG
• Gastroparesis: Delayed gastric emptying can predate pregnancy or worsen dramatically during it
• Appendicitis: The appendix shifts position during pregnancy; right-sided pain with vomiting in any trimester warrants evaluation
• Cholecystitis: Gallstones become more common in pregnancy due to hormonal changes in bile composition; right upper quadrant pain, fatty food intolerance, and vomiting are the classic triad

Urinary Tract Infections and Pyelonephritis

Pregnant women are at higher risk of urinary tract infections and pyelonephritis due to the urinary tract changes of pregnancy. Pyelonephritis can present with nausea, vomiting, and flank pain. A urine culture should be part of the workup for any woman with HG symptoms to exclude infection.

Neurological Causes

Vestibular disorders, migraines, and, rarely, increased intracranial pressure can cause severe intractable vomiting. Neurological symptoms including severe headache, visual changes, focal weakness, or loss of balance alongside vomiting warrant imaging.

Metabolic and Endocrine Causes

Diabetic ketoacidosis can occur at lower glucose thresholds in pregnancy than outside of it and presents with nausea and vomiting. Addison's disease and hypercalcemia, though rare, also cause severe nausea. A basic metabolic panel, glucose, and electrolytes help sort these out.

Molar Pregnancy and Multiple Gestation

Both conditions produce very high hCG levels and carry a significantly higher risk of hyperemesis. An early ultrasound, which is standard practice when hyperemesis is diagnosed, establishes the number of fetuses and rules out molar pregnancy.

Diagnosing Hyperemesis: What Tests Your Clinician Should Order

There is no single blood test that diagnoses hyperemesis. The diagnosis is clinical, meaning it is based on your symptoms and their impact. But laboratory testing is essential to assess severity and rule out other causes.

Recommended Initial Workup

• Urine dipstick for ketones: Ketonuria reflects inadequate carbohydrate intake and dehydration. ACOG recommends urine ketones as part of the initial assessment.
• Complete metabolic panel: Assesses sodium, potassium, chloride, bicarbonate, liver enzymes, and creatinine. Hypokalemia, hyponatremia, and elevated creatinine indicate clinically significant dehydration.
• Thyroid function tests (TSH, free T4): Rule out GTT and Graves' disease.
• Complete blood count: Anemia is common in pregnancy; hemoconcentration may indicate dehydration.
• Urine culture: Excludes urinary tract infection.
• Liver function tests: Transaminase elevations occur in 50% of hospitalized HG cases and, when severe, suggest a complication.
• Pelvic ultrasound: Rules out molar pregnancy and confirms gestational age and number of fetuses.

Severity Scoring

The Pregnancy-Unique Quantification of Emesis and Nausea (PUQE) score is a validated tool that quantifies the severity of nausea and vomiting in pregnancy based on three questions about hours of nausea, vomiting episodes, and retching. A PUQE score of 13 or higher indicates severe disease. Ask your provider to use it, or use it yourself to track whether you are improving or getting worse.

Pregnancy and Lactation: Medications and Safety

Hyperemesis is a pregnancy condition, so every treatment decision carries two patients: you and your baby. This section covers the evidence on safety, not to scare you, but to help you make informed decisions and push back if someone dismisses your need for treatment.

First-Line: Pyridoxine (Vitamin B6) and Doxylamine

The combination of pyridoxine 10 mg plus doxylamine 10 mg (available as Diclegis or Bonjesta in the US) is the only FDA-approved pharmacologic treatment for nausea and vomiting of pregnancy. Extensive post-marketing surveillance and the Motherisk database support its safety. It does not increase the risk of major malformations. The FDA approved it based on a randomized controlled trial showing a 4.8-point reduction in PUQE score versus placebo.

Antihistamines

Promethazine and diphenhydramine are pregnancy category B antihistamines used for nausea. Both cross the placenta but have not been associated with major fetal malformations. Near term, promethazine can cause neonatal respiratory depression, so timing of use matters.

Ondansetron (Zofran)

Ondansetron is frequently prescribed for HG, though it is used off-label for this indication. Earlier studies raised concerns about a possible link to oral clefts, but a large Danish cohort study of 608,385 pregnancies found no significant increase in cardiac malformations or oral clefts with first-trimester ondansetron use. ACOG notes that ondansetron may be used when first-line treatments fail. You and your clinician should weigh severity of untreated HG, which itself carries fetal risks from nutritional deprivation, against the small and still-debated theoretical risk.

Corticosteroids

Methylprednisolone is sometimes used for refractory HG. First-trimester use has been associated with a possible small increased risk of oral clefts in some studies. It is generally reserved for cases that fail all other treatments.

Metoclopramide

Metoclopramide is considered compatible with pregnancy and works by accelerating gastric emptying. Long-term use can cause tardive dyskinesia, a movement disorder, so it should not be used for more than 12 consecutive weeks.

IV Fluids and Thiamine

Women hospitalized with HG require IV rehydration. Before giving dextrose-containing fluids, thiamine (vitamin B1, at least 100 mg IV) must be given to prevent Wernicke encephalopathy, a serious neurological complication of thiamine deficiency caused by prolonged vomiting and poor intake. ACOG specifically recommends thiamine supplementation before dextrose infusion in women who have vomited for more than 3 weeks.

Enteral and Parenteral Nutrition

In severe, refractory cases, nasogastric or nasojejunal tube feeding may be needed to maintain maternal and fetal nutrition. Total parenteral nutrition (TPN) is reserved for cases where enteral feeding is not tolerated, given the risk of central line infections and other complications.

Lactation

Most medications used for HG, including pyridoxine-doxylamine, ondansetron, and metoclopramide, are not contraindicated during breastfeeding, though the postpartum period is generally not when HG is active. If you are postpartum and experiencing severe nausea and vomiting, the cause is not hyperemesis gravidarum. Seek evaluation for other diagnoses.

When to Go to the Emergency Department

Some symptoms mean you should not wait for a telehealth appointment. Go to an emergency department or call 911 if you have:

• No urine output for 8 or more hours or very dark brown urine
• Bloody or coffee-ground vomit (possible upper GI bleed)
• Severe right-sided abdominal pain (appendicitis, cholecystitis)
• High fever alongside vomiting (infection, pyelonephritis)
• Confusion, difficulty speaking, or vision changes (neurological cause, Wernicke encephalopathy)
• Fainting or inability to stand without passing out
• Rapid heart rate above 120 beats per minute at rest

Who Is at Higher Risk: Life-Stage and Condition-Specific Risk Factors

Not every pregnant woman has equal risk of developing hyperemesis. Certain factors raise your probability substantially.

Reproductive Years and First Pregnancy

First-time pregnancies carry a modestly higher rate of HG, possibly because there is no prior immune or physiological adaptation to fetal antigens. Women under 30 may have slightly higher risk in some studies, though data are inconsistent.

PCOS and Metabolic Factors

Women with polycystic ovary syndrome have an elevated prevalence of HG, possibly related to differences in ovarian hormone production, insulin resistance, and gastric motility. If you have PCOS and are pregnant, discuss HG risk with your provider early so a management plan is in place before symptoms escalate.

Multiple Gestation

Carrying twins or higher-order multiples dramatically increases hCG levels and with them, nausea severity. Women who conceive via IVF, who are more likely to carry multiples, should be counseled about HG risk before embryo transfer.

Prior History of HG or Motion Sickness

A personal history of HG in a previous pregnancy predicts HG in the next one, with recurrence rates between 15 and 81% depending on the series. A history of motion sickness or migraines also increases susceptibility, likely through shared vestibular and central nervous system pathways.

Psychological Impact Deserves Recognition

Women with HG have higher rates of depression, anxiety, and in severe cases, post-traumatic stress. The condition has been associated with pregnancy termination in wanted pregnancies because the suffering is so severe and so undertreated. One UK survey found that 10% of women with HG terminated a wanted pregnancy because of inadequate symptom control. This is not a minor quality-of-life issue. It is a serious medical condition that warrants aggressive treatment.

Treatment Beyond Medications: What Actually Helps

Medication is often necessary, but several non-pharmacological strategies have evidence or strong clinical consensus behind them.

Dietary Adjustments

• Eat small, frequent meals rather than three large ones. An empty stomach worsens nausea.
• Cold or room-temperature foods tend to be better tolerated than hot foods because heat amplifies smell.
• Protein-rich snacks before getting out of bed may reduce morning severity.
• Bland carbohydrates (saltine crackers, plain rice, toast) are traditional but have limited evidence. Protein may actually work better.
• Avoid fatty, spicy, or strongly scented foods.

Ginger

A Cochrane review found ginger modestly reduces nausea in the first trimester, though the effect on vomiting is less clear. Ginger tea, ginger chews, or 250 mg capsules taken four times daily are reasonable adjuncts to medication, not replacements for it in true hyperemesis.

Acupressure

Stimulation of the P6 (Nei-Kuan) point on the inner wrist via acupressure wristbands has mixed evidence. Some women find it helpful for mild to moderate nausea. For severe hyperemesis, it is unlikely to be sufficient alone.

Thiamine Supplementation

Any woman with prolonged vomiting and restricted intake should take thiamine 1.5 mg daily at minimum, or receive IV thiamine if hospitalized. This prevents the rare but devastating neurological complication of Wernicke encephalopathy.

Mental Health Support

Psychological support, including cognitive behavioral therapy adapted for HG, peer support groups (the HER Foundation has a peer network), and in some cases medication for co-occurring depression and anxiety, should be part of comprehensive care. ACOG recommends screening for depression and anxiety in women with hyperemesis gravidarum.

What Happens If HG Goes Untreated

The consequences of untreated hyperemesis are not trivial for you or your baby.

For you: significant muscle wasting, vitamin deficiencies (particularly thiamine, folate, and B12), electrolyte crises, Wernicke encephalopathy in the most severe cases, and a higher rate of depression and anxiety both during and after pregnancy.

For your baby: women who lose more than 5% of their pre-pregnancy weight from HG have higher rates of low birth weight and small-for-gestational-age infants. Preterm birth rates are also elevated in severe, untreated cases. Adequate nutrition and hydration directly shape fetal growth and outcome.

The evidence gap is real here. Most clinical trials of HG treatments have been small and of limited quality. As ACOG acknowledges in its Practice Bulletin on nausea and vomiting of pregnancy, much of what clinicians practice is based on expert consensus rather than large randomized trials. You deserve to know that, and you also deserve to know that withholding treatment to protect the baby from unproven medication risks is often the riskier choice when weighed against the documented harms of untreated HG.

A Note on Evidence Gaps

Women have been historically underrepresented in clinical trials, and obstetric conditions have often been studied in small, underpowered cohorts out of concern for fetal harm from trial participation. Hyperemesis research is particularly thin for women of color, women with PCOS, and women from lower-income settings where IV hydration access is limited. The 2024 GDF15 findings from Fejzo et al. Represent the most significant mechanistic advance in understanding this condition in decades, and they open the door to potential targeted therapies (GDF15 receptor modulators are in early development). For now, treatment remains largely supportive, but the science is finally catching up to the severity of the condition.